Edition:
United States

T2 Biosystems Inc (TTOO.OQ)

TTOO.OQ on NASDAQ Stock Exchange Global Market

6.96USD
1:03pm EDT
Change (% chg)

$-0.02 (-0.29%)
Prev Close
$6.98
Open
$6.96
Day's High
$7.04
Day's Low
$6.87
Volume
17,611
Avg. Vol
66,530
52-wk High
$7.51
52-wk Low
$2.51

Select another date:

Mon, Mar 19 2018

BRIEF-T2 Biosystems Files For Non Timely 10-K

* T2 BIOSYSTEMS INC FILES FOR NON TIMELY 10-K - SEC FILING‍​ Source text - http://bit.ly/2ppkjtC Further company coverage:

BRIEF-T2 Biosystems Q4 Revenue Rose 55 Percent To $1.7 Million

* T2 BIOSYSTEMS REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

BRIEF-T2 Biosystems Awarded Up To $2 Million By Carb-X To Support Development Of New Tests On The T2Dx Instrument For Drug-Resistant Bacteria

* T2 BIOSYSTEMS AWARDED UP TO $2 MILLION BY CARB-X TO SUPPORT DEVELOPMENT OF NEW TESTS ON THE T2DX INSTRUMENT FOR DRUG-RESISTANT BACTERIA Source text for Eikon: Further company coverage:

BRIEF-T2 Biosystems Says John Sprague Has Been Named CFO

* T2 BIOSYSTEMS INC - JOHN SPRAGUE HAS BEEN NAMED CHIEF FINANCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-T2 Biosystems CFO Darlene Deptula-Hicks Resigns

* T2 BIOSYSTEMS- ON JAN 30, DARLENE DEPTULA-HICKS NOTIFIED CO OF HER RESIGNATION FROM POSITION AS CO'S CHIEF FINANCIAL OFFICER EFFECTIVE IMMEDIATELY

BRIEF-T2 Biosystems Says ‍Total Q4 Revenue Is Expected To Exceed Previously Guided Range Of $1.1 Mln To $1.3 Mln​

* T2 BIOSYSTEMS ANNOUNCES PRELIMINARY FOURTH QUARTER 2017 FINANCIAL RESULTS AND PROVIDES UPDATE ON T2BACTERIA PANEL

BRIEF-T2 Biosystems, SMC Ltd Amend Certain Supply Agreement

* T2 BIOSYSTEMS-ON DEC. 22, CO,SMC, LTD ENTERED INTO SECOND AMENDMENT TO SUPPLY AGREEMENT, AMENDING CERTAIN SUPPLY AGREEMENT, DATED AS OF OCT. 10, 2014

BRIEF-T2 Biosystems Q3 loss per share $0.45

* T2 biosystems reports third quarter 2017 financial results and provides company update

Select another date: